Estimation application downloads and cost
Description
Respirex chemically protective suits, jackets and trousers offer best-in-class protection against a broad range of chemical hazards encountered in the workplace. All garments are type approved and CE marked to the relevant European standards.
PermaSURE is the latest innovation. It is a software modeller App that puts you in control. When wearing a Chemprotex garment, it provides you with both toxicity information and a guide as to how long you can be exposed to a challenge chemical before harmful toxicity limits are reached.
Read more
PermaSURE is the latest innovation. It is a software modeller App that puts you in control. When wearing a Chemprotex garment, it provides you with both toxicity information and a guide as to how long you can be exposed to a challenge chemical before harmful toxicity limits are reached.
Respirex Chemprotex screenshorts
ASO analyse Respirex Chemprotex app for iPhone and iPad
No search terms founded
Competitors of Respirex Chemprotex application
Application availability
Available in countries
| Country | Price |
|---|---|
| Canada | free |
| China | free |
| France | free |
| Germany | free |
| Italy | free |
| Netherlands | free |
| Portugal | free |
| Spain | free |
| UK | free |
| India | free |
| Japan | free |
| Korea, Republic Of | free |
| Poland | free |
| Russia | free |
| Turkey | free |
| USA | free |
| Korea, Republic Of | free |
| Ukraine | free |
Available for devices
iPad2Wifi, iPad23G, iPhone4S, iPadThirdGen, iPadThirdGen4G, iPhone5, iPodTouchFifthGen, iPadFourthGen, iPadFourthGen4G, iPadMini, iPadMini4G, iPhone5c, iPhone5s, iPadAir, iPadAirCellular, iPadMiniRetina, iPadMiniRetinaCellular, iPhone6, iPhone6Plus, iPadAir2, iPadAir2Cellular, iPadMini3, iPadMini3Cellular, iPodTouchSixthGen, iPhone6s, iPhone6sPlus, iPadMini4, iPadMini4Cellular, iPadPro, iPadProCellular, iPadPro97, iPadPro97Cellular, iPhoneSE, iPhone7, iPhone7Plus, iPad611, iPad612, iPad71, iPad72, iPad73, iPad74, iPhone8, iPhone8Plus, iPhoneX,Other apps from Russell Broadbent
